drugset / Trial / NCT01523301
Rotigotine Versus Placebo to Evaluate the Efficacy on Depressive Symptoms in Idiopathic Parkinson's Disease Patients
RandomizedParallel-groupDouble-blindTreatment
Summary
The purpose of this study was to show superiority of Rotigotine over placebo on improvement of depressive symptoms in subjects with idiopathic Parkinson's disease.
Timeline
- Start
- 2012-04
- Primary completion
- 2014-10
- Completion
- 2014-10
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Rotigotine | Unknown | 8 mg | Other |
| Subject | Rotigotine | Unknown | 16 mg | Other |